To include your compound in the COVID-19 Resource Center, submit it here.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will acquire a 51% stake in computational genomic analysis company Immuneering Corp. (Cambridge, Mass.). Teva
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury